Aurora Cannabis (TSE:ACB – Get Free Report) announced its quarterly earnings results on Thursday. The company reported C$0.05 earnings per share (EPS) for the quarter, FiscalAI reports. The firm had revenue of C$86.02 million during the quarter. Aurora Cannabis had a negative return on equity of 5.21% and a negative net margin of 9.53%.
Aurora Cannabis Price Performance
Shares of TSE:ACB opened at C$7.29 on Friday. The company’s 50 day moving average is C$5.79 and its 200 day moving average is C$4.95. The company has a market cap of C$461.53 million, a PE ratio of -3.76 and a beta of 0.26. The company has a current ratio of 5.36, a quick ratio of 2.48 and a debt-to-equity ratio of 4.30. Aurora Cannabis has a twelve month low of C$3.59 and a twelve month high of C$8.75.
Analyst Upgrades and Downgrades
ACB has been the subject of a number of recent research reports. TD downgraded shares of Aurora Cannabis from a “buy” rating to a “sell” rating and reduced their price objective for the stock from C$8.00 to C$7.80 in a research note on Wednesday. ATB Cormark Capital Markets lifted their price target on Aurora Cannabis from C$5.60 to C$7.00 and gave the company a “tender” rating in a report on Tuesday, October 6th. BMO Capital Markets raised Aurora Cannabis to a “hold” rating in a research report on Wednesday, August 5th. Finally, TD Securities downgraded Aurora Cannabis from a “strong-buy” rating to a “strong sell” rating in a research report on Tuesday. One analyst has rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Reduce” and a consensus target price of C$6.60.
Get Our Latest Stock Analysis on ACB
Aurora Cannabis Company Profile
Aurora is Opening the World to Cannabis ¿, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company’s adult-use brand portfolio includes Drift , San Raf , Daily Special ¿, Tasty’s ¿, Being and Greybeard . Medical cannabis brands include MedReleaf , CanniMed , Aurora and Whistler Medical Marijuana Corporation , as well as international brands, Pedanios , IndiMed ¿ and CraftPlant ¿.
Featured Stories
- Five stocks we like better than Aurora Cannabis
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
